Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Novel neuraminidase inhibitors described by U. of Florida

March 11, 1999

Ziracin: lead compound from a new class of antibiotics in late-stage trials at Schering-Plough

March 10, 1999

Avanir submits additional efficacy data for docosanol cream to FDA

March 9, 1999

FDA advisory committee declines to recommend approval of Locilex

March 5, 1999

Taisho scientists isolate and and characterize new antifungal agent

March 5, 1999

Wyeth-Ayerst to market Abelcet in the U.K.

March 5, 1999

Novartis obtains first western approval for new antimalarial drug combination

March 4, 1999

Pfizer claims new, improved compositions of alatrofloxacin

March 4, 1999

New lantibiotic isolated and characterized by U. of Maryland group

March 4, 1999

Cubist Pharmaceuticals initiates pivotal clinical trials for daptomycin

March 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...